The National Community Pharmacists Association (NCPA) has expressed approval following the House of Representatives' passage of a budget reconciliation bill. Read More »

The Georgia Board of Pharmacy has issued a safety alert regarding compromised drug products. Read More »

Americans are expressing a strong desire for increased accountability from pharmaceutical companies regarding vaccine safety, according to a recent poll. Read More »

Pfizer and Moderna are required to update their COVID-19 vaccine labels to include stronger warnings about potential heart damage, according to the U.S. Food and Drug Administration (FDA). Read More »

The National Consumers League (NCL) has announced the results of a national Morning Consult poll, which reveals significant public support for comprehensive reforms to the 340B Drug Pricing Program. Read More »

The Michigan Department of Licensing and Regulatory Affairs (LARA) has introduced its inaugural podcast, "LARA Living Room," during the Mackinac Policy Conference. Read More »

Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »

Empower Clinic Services LLC, a compounding pharmacy based in Houston, has petitioned the U.S. Patent Trial and Appeal Board (PTAB) to invalidate Eli Lilly & Co. Read More »

David Balto, a former policy director at the Federal Trade Commission (FTC), has raised concerns about the 340B drug discount program, alleging that it is being manipulated by corporate hospital systems and large pharmacies to the detriment of... Read More »

The South Dakota Department of Agriculture and Natural Resources (DANR) and the Department of Health (DOH) have issued an air quality alert for the state. Read More »